Crossmark Global Holdings Inc. lowered its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 4.4% during the fourth quarter, Holdings Channel reports. The fund owned 13,929 shares of the medical equipment provider’s stock after selling 640 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Varian Medical Systems were worth $1,548,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. WASHINGTON TRUST Co grew its position in Varian Medical Systems by 100.0% during the 4th quarter. WASHINGTON TRUST Co now owns 970 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 485 shares during the last quarter. Catawba Capital Management VA bought a new stake in shares of Varian Medical Systems in the 4th quarter valued at about $210,000. Convergence Investment Partners LLC bought a new stake in shares of Varian Medical Systems in the 3rd quarter valued at about $219,000. Advisor Partners LLC bought a new stake in shares of Varian Medical Systems in the 4th quarter valued at about $223,000. Finally, Parametrica Management Ltd bought a new stake in shares of Varian Medical Systems in the 3rd quarter valued at about $229,000. Institutional investors and hedge funds own 99.19% of the company’s stock.

A number of equities research analysts have commented on VAR shares. Citigroup upped their price target on Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. Zacks Investment Research upgraded Varian Medical Systems from a “sell” rating to a “hold” rating in a research report on Monday, January 29th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Royal Bank of Canada set a $105.00 price target on Varian Medical Systems and gave the company a “hold” rating in a research report on Thursday, November 30th. Finally, JPMorgan Chase & Co. upped their price target on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $108.44.

Shares of Varian Medical Systems, Inc. (NYSE VAR) opened at $116.24 on Wednesday. Varian Medical Systems, Inc. has a 52-week low of $79.86 and a 52-week high of $130.29. The company has a market capitalization of $10,453.88, a PE ratio of 92.99, a price-to-earnings-growth ratio of 3.32 and a beta of 0.81.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.06. The company had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The firm’s revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.09 EPS. equities analysts expect that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current year.

In other news, Director Timothy E. Guertin sold 10,000 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $111.46, for a total value of $1,114,600.00. Following the transaction, the director now directly owns 2,161 shares of the company’s stock, valued at approximately $240,865.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark R. Laret sold 2,161 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $126.97, for a total value of $274,382.17. The disclosure for this sale can be found here. Insiders sold a total of 146,211 shares of company stock worth $16,683,318 over the last three months. 0.78% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/14/crossmark-global-holdings-inc-trims-position-in-varian-medical-systems-inc-var.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.